Economic consequences of idiopathic pulmonary fibrosis in Denmark

ERJ Open Res. 2018 May 25;4(2):00045-2017. doi: 10.1183/23120541.00045-2017. eCollection 2018 Apr.

Abstract

When a patient is diagnosed with IPF, the net health costs increase from €2753 to €21 184 per year even without the cost of antifibrotic treatment. Inpatient treatment accounts for the main part of the expenses http://ow.ly/dSsn30jEx0p.